Cargando…

Cefquinome Sulfate Oily Nanosuspension Designed for Improving its Bioavailability in the Treatment of Veterinary Infections

INTRODUCTION: Cefquinome sulfate (CS) is the first fourth-generation antibiotic for animals, which has a wide antibacterial spectrum, strong antibacterial activity and low drug resistance. However, it is accompanied by problems of poor therapeutic efficacy. In this context, the use of nanosuspension...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Yujuan, Chen, Yumeng, Liu, Chang, He, Xingyue, Zheng, Yi, Chen, Xiaolan, Wang, Ying, Chen, Wei, Wu, Yanling, Shen, Yan, Yang, Haifeng, Ma, Songbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169852/ https://www.ncbi.nlm.nih.gov/pubmed/35677677 http://dx.doi.org/10.2147/IJN.S348822

Ejemplares similares

Preparation of Cefquinome Sulfate Proliposome and its Pharmacokinetics in Rabbit
por: FU, Qiang, et al.
Publicado: (2013)

Elimination of Cefquinome Sulfate Residue in Cow’s Milk after Intrauterine Infusion
por: Liu, Chunshuang, et al.
Publicado: (2023)

Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions
por: Li, Haowen, et al.
Publicado: (2021)

Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement
por: Thakkar, Hetal Paresh, et al.
Publicado: (2011)

Improving Breviscapine Oral Bioavailability by Preparing Nanosuspensions, Liposomes and Phospholipid Complexes
por: Song, Zilin, et al.
Publicado: (2021)

Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus)
por: Zhao, Dong-Hao, et al.
Publicado: (2017)

Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin
por: Li, Jun, et al.
Publicado: (2018)

In vitro dissolution and bioavailability study of furosemide nanosuspension prepared using design of experiment (DoE)
por: Shariare, Mohammad H., et al.
Publicado: (2019)

Preparation and characterization of amorphous ezetimibe nanosuspensions intended for enhancement of oral bioavailability
por: Thadkala, Kiran, et al.
Publicado: (2014)

Enhanced bioavailability of danazol nanosuspensions by wet milling and high-pressure homogenization
por: Kanthamneni, Naveen, et al.
Publicado: (2016)

Development and Evaluation of Tannic Acid-Coated Nanosuspension for Enhancing Oral Bioavailability of Curcumin
por: Lee, Hyeonmin, et al.
Publicado: (2021)

Nanosuspensions and Microneedles Roller as a Combined Approach to Enhance Diclofenac Topical Bioavailability
por: Pireddu, Rosa, et al.
Publicado: (2020)

Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems – enhancement of oral bioavailability
por: Hashem, Fahima M, et al.
Publicado: (2015)

Development of Stability-Indicating Methods for Cefquinome Sulphate
por: Shantier, Shaza W., et al.
Publicado: (2013)

Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3(2) Factorial Design to Improve Solubility and In Vitro Bioavailability
por: Alhamhoom, Yahya, et al.
Publicado: (2023)

Enhanced oral bioavailability of magnolol via mixed micelles and nanosuspensions based on Soluplus(®)-Poloxamer 188
por: Li, Guoyuan, et al.
Publicado: (2020)

Stability of Ceftiofur Sodium and Cefquinome Sulphate in Intravenous Solutions
por: Dołhań, Agnieszka, et al.
Publicado: (2014)

Systematic Development of Self-Nanoemulsifying Liquisolid Tablets to Improve the Dissolution and Oral Bioavailability of an Oily Drug, Vitamin K1
por: Tong, Yongtao, et al.
Publicado: (2018)

Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability
por: Rahim, Haroon, et al.
Publicado: (2020)

Quality-by-Design approach to the fluid-bed coating of ginkgo lactone nanosuspensions
por: Han, Jiawei, et al.
Publicado: (2018)

The pharmacokinetics and pharmacodynamics of cefquinome against Streptococcus agalactiae in a murine mastitis model
por: Yang, Qingwen, et al.
Publicado: (2023)

Determination of Susceptibility Breakpoint for Cefquinome against Streptococcus suis in Pigs
por: Mi, Kun, et al.
Publicado: (2021)

Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition
por: Rahim, Haroon, et al.
Publicado: (2019)

Development of Nanosuspension of Artemisia absinthium Extract as Novel Drug Delivery System to Enhance Its Bioavailability and Hepatoprotective Potential
por: Jahan, Nazish, et al.
Publicado: (2023)

Preparation, characterization and pharmacokinetics of cyadox nanosuspension
por: Sattar, Adeel, et al.
Publicado: (2017)

Dose Assessment of Cefquinome by Pharmacokinetic/Pharmacodynamic Modeling in Mouse Model of Staphylococcus aureus Mastitis
por: Yu, Yang, et al.
Publicado: (2016)

Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Actinobacillus pleuropneumoniae
por: Zhang, Longfei, et al.
Publicado: (2020)

Effect of Repeated Administration of Cefquinome on Biochemical and Hematological Parameters in Buffalo Calves
por: Mangal, Mukesh, et al.
Publicado: (2015)

Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China
por: Mi, Kun, et al.
Publicado: (2021)

Disposition of Cefquinome in Turkeys (Meleagris gallopavo) Following Intravenous and Intramuscular Administration
por: Elbadawy, Mohamed, et al.
Publicado: (2021)

Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum]
Publicado: (2020)

Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia
por: Bartos, Csaba, et al.
Publicado: (2019)

Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Retraction]
Publicado: (2022)

Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate
por: Qiao, Hongzhi, et al.
Publicado: (2017)

Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
por: Ahmad, Ijaz, et al.
Publicado: (2015)

Novel redispersible nanosuspensions stabilized by co-processed nanocrystalline cellulose–sodium carboxymethyl starch for enhancing dissolution and oral bioavailability of baicalin
por: Xie, Jin, et al.
Publicado: (2019)

Quality by Design Optimization of Cold Sonochemical Synthesis of Zidovudine-Lamivudine Nanosuspensions
por: Witika, Bwalya A., et al.
Publicado: (2020)

Studying the effect of reactor design on the electrocoagulation treatment performance of oily wastewater
por: Jasim, Muhammad Aiyd, et al.
Publicado: (2023)

Study on Formulation, in vivo Exposure, and Passive Targeting of Intravenous Itraconazole Nanosuspensions
por: Yuan, Qi, et al.
Publicado: (2019)

In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion
por: Yu, Yang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1tcko2mv65995k56t6ps07nd3c